• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941848250
Medical Device Problem Codes Break (1069); Difficult to Remove (1528)
Health Effect - Clinical Codes Chest Pain (1776); Low Blood Pressure/ Hypotension (1914); Perforation (2001)
Date of Event 01/10/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that difficulty removal, shaft break, and perforation occurred.The 100% stenosed target lesion was located in the severely tortuous and severely calcified mid right coronary artery (rca).A 2.50 x 48mm synergy xd drug-eluting stent was placed in the mid rca.However, the stent balloon would not pull back.The physician tried to remove the balloon but the shaft broke 25cm from the hypotube at the flexible distal portion.A balloon was placed distal to the broken shaft, inflated and dragged the broken device back into the guide.Furthermore, a perforation was noted at the mid rca.The patient became hypotensive and experienced chest pain.The perforation was treated with balloon tamponade.The procedure was prolonged but was able to be completed with a different device.No further patient but they were complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: a synergy xd mr us 2.50 x 48mm stent delivery system was returned for analysis.The device was returned without the stent as it was implanted at the lesion site.The balloon cones were reviewed, and signs of positive pressure applied to them were noted as the balloon folds were noted to be relaxed and crimp stent markings were visible on the balloon body.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube found multiple kinks along the length of the hypotube shaft.A visual and tactile examination of the outer and mid-shaft section found a break at the exchange port region of the shaft polymer extrusion.No other issues noted with device.
 
Event or Problem Description
It was reported that difficulty removal, shaft break, and perforation occurred.The 100% stenosed target lesion was located in the severely tortuous and severely calcified mid right coronary artery (rca).A 2.50 x 48mm synergy xd drug-eluting stent was placed in the mid rca.However, the stent balloon would not pull back.The physician tried to remove the balloon but the shaft broke 25cm from the hypotube at the flexible distal portion.A balloon was placed distal to the broken shaft, inflated and dragged the broken device back into the guide.Furthermore, a perforation was noted at the mid rca.The patient became hypotensive and experienced chest pain.The perforation was treated with balloon tamponade.The procedure was prolonged but was able to be completed with a different device.No further patient but they were complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13295492
Report Number2134265-2022-00410
Device Sequence Number17352294
Product Code NIQ
UDI-Device Identifier08714729985204
UDI-Public08714729985204
Combination Product (Y/N)Y
Initial Reporter StateNY
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/24/2023
Device Model NumberH7493941848250
Device Lot Number0027994048
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/11/2022
Supplement Date Received by Manufacturer04/12/2022
Initial Report FDA Received Date01/19/2022
Supplement Report FDA Received Date04/15/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/24/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient Age82 YR
Patient SexFemale
Patient Weight76 KG
Patient RaceBlack Or African American
-
-